Abstract

Objectives
Jaundice occurs in 60% of full-term and 80% of pre-term newborns. This study compared the effect of phototherapy with and without phenobarbital on icteric newborns.
Materials & Methods
This study is a randomized clinical trial conducted from July until March 2018 at Imam Reza Hospital, Mashhad University of Medical Science, Iran. Full-term and near-term neonates with more than 2000 grams who were hospitalized in the mentioned period for jaundice were entered into the study. The newborns were divided into two groups using block randomization. Data were analyzed by SPSS version 19.
Results
The average gestational age was 36.4 weeks (SD 2.39) in the intervention group and 36.9 weeks (SD 2.16) in the control group, with no significant difference between them. The mean hospital stay for the intervention group was 72 hours (SD 1.66), compared to 55 hours (SD 1.88) for the control group. At discharge, the serum bilirubin level in the intervention group was 11.53 mg/dL (SD 0.77), while it was 10.80 mg/dL (SD 1.09) in the control group, a statistically significant difference.
Conclusion
According to this study, phototherapy with phenobarbital is not more effective than phototherapy alone in neonatal hyperbilirubinemia.

 

Keywords: Kye Words: newborn, phenobarbital, hyperbilirubinemia, phototherapy How to Cite

Shah Farhat, A., saeidi, raza, Mohammadzadeh , A. ., Lotfi, S. R. ., & hajipour, mahmoud. (2024). Comparison of Phototherapy Effect with and without Phenobarbital on the Newborns with Hyperbilirubinemia. Iranian Journal of Child Neurology, 18(2), 23–29. https://doi.org/10.22037/ijcn.v18i2.36848

References

1- Ip S, Chung M, Kulig J, SEGE R, GLICKEN S, MAISELS M, et al. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. 2004
2- Mreihil.K, Benth.JŠ, Stensvold.HJ, Nakstad.B, HansenTW. Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants. Acta Paediatrica Apr. 2018;107(4):611-9.
3- Sarici SÜ, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004;113(4):775-80.
4- Scrafford CG, Mullany LC, Katz J, Khatry SK, LeClerq SC, Darmstadt GL, et al. Incidence of and risk factors for neonatal jaundice among newborns in southern N epal. Tropical Medicine & International Health. 2013;18(11):1317-28.
5- Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, et al. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia. 2010;53(4):641-51.
6- Arya VB, Agarwal R, Paul VK, Deorari AK. Efficacy of oral phenobarbitone in term" at risk" neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial. Indian pediatrics. 2004;41(4):327-34.
7- Hansen TWR. Therapeutic approaches to neonatal jaundice: an international survey. Clinical pediatrics. 1996;35(6):309-16.
8- Pashapoor.N, A AM, A A, S. G. Comparison of phenobarbital therapy and phototherapy with phototherapy in the treatment of non-hemolytic hyperbilirubinemia in term neonates. Quarterly Journal of nursing and midwifery Uromia. 2007;5(2):7-11.
9- FaM. Neonatal & perinatal medicine edition t, editor. Philadelphia PA2015.
10- Kaabneh MA, Salama GS, Shakkoury AG, Al-Abdallah IM, Alshamari A, Halaseh RA. Phenobarbital and phototherapy combination enhances decline of total serum bilirubin and may decrease the need for blood exchange transfusion in newborns with isoimmune hemolytic disease. Clinical Medicine Insights: Pediatrics. 2015;9:CMPed. S24909.
11- Thomas JT, Muller P, Wilkinson C. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. The Cochrane database of systematic reviews. 2007(2):CD005541-CD.
12- Chawla D, Parmar V. Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis. Indian pediatrics. 2010;47(5):401-7.
13- Ahadi A, Mirzarahimi M, Ahmadabadi F, Tavasoli A, Parvaneh N. Comparison of the efficacy of Clofibrate with Phenobarbital in decreasing neonatal hyperbilirubinemia. Iranian Journal of Neonatology IJN. 2013;4(3):13-9.
14- Rembolt RR. Cerebral Palsy and Related Disorders, Prevention and Early Care: An Annotated Bibliography. Volume I, Part One. 1972.
15- De Carvalho M. Treatment of neonatal hyperbilirubinemia. J Pediatr. 2001;77(Suppl 1):S71-S80